两剂次皮内注射组分灭活脊髓灰质炎疫苗后对2型脊髓灰质炎病毒的免疫原性:一种新型剂量节约免疫程序
为应对全球2型口服脊髓灰质炎病毒移除后灭活脊髓灰质炎疫苗(IPV)供应紧张,本文通过文献综述与作者联系,比较两剂次皮内注射五分之一剂量IPV(fIPV)与一剂次全剂量IPV对2型脊髓灰质炎病毒的免疫原性。共识别4项研究,两剂次fIPV的2型血清阳转率较一剂次全剂量IPV绝对提高19–42%(中位数37%,p<0.001),相对提高53–125%(中位数82%),2型抗体滴度升高2–32倍(中位数10倍)。
要点
- 两剂次fIPV对2型脊髓灰质炎病毒的免疫原性优于一剂次全剂量IPV。
- 2型血清阳转率绝对提高19–42%(中位数37%,p<0.001),相对提高53–125%(中位数82%)。
- 2型抗体滴度升高2–32倍(中位数10倍);接种年龄小和间隔短与免疫原性较低相关。
核心结论
- 总体而言,两剂次fIPV比一剂次全剂量IPV免疫原性更强,与血清阳转率和抗体滴度显著增加相关。
研究设计与样本
- 本文为文献综述,并联系近期fIPV研究的通讯作者,补充进行两剂次fIPV与一剂次全剂量IPV的2型免疫原性分析。
- 共识别4项评估两剂次fIPV与一剂次全剂量IPV免疫原性的研究。
主要发现
- 两剂次fIPV的2型血清阳转率较一剂次全剂量IPV绝对提高19–42%(中位数37%,p<0.001)。
- 两剂次fIPV的2型血清阳转率相对提高53–125%(中位数82%)。
- 两剂次fIPV的2型抗体滴度升高2–32倍(中位数10倍)。
- 接种年龄小和两剂间隔短与免疫原性较低相关。
临床怎么用
- 为应对当前IPV短缺,技术监督委员会已认可6周龄和14周龄接种两剂次fIPV的程序,并已在部分受影响国家引入。
- 两剂次fIPV合计使用一剂次全剂量IPV五分之二的疫苗量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The polio eradication endgame strategic plan calls for the sequential removal of Sabin poliovirus serotypes from the trivalent oral poliovirus vaccine (tOPV), starting with type 2, and the introduction of ≥1 dose of inactivated poliovirus vaccine (IPV), to maintain an immunity base against poliovirus type 2. The global removal of oral poliovirus type 2 was successfully implemented in May 2016. However, IPV supply constraints has prevented introduction in 21 countries and led to complete stock-out in >20 countries. METHODS: We conducted a literature review and contacted corresponding authors of recent studies with fractional-dose IPV (fIPV), one-fifth of intramuscular dose administered intradermally, to conduct additional type 2 immunogenicity analyses of two fIPV doses compared with one full-dose IPV. RESULTS: Four studies were identified that assessed immunogenicity of two fIPV doses compared to one full-dose IPV. Two fractional doses are more immunogenic than 1 full-dose, with type 2 seroconversion rates improving between absolute 19-42% (median: 37%, p<0.001) and relative increase of 53-125% (median: 82%), and antibody titer to type 2 increasing by 2-32-fold (median: 10-fold). Early age of administration and shorter intervals between doses were associated with lower immunogenicity. DISCUSSION: Overall, two fIPV doses are more immunogenic than a single full-dose, associated with significantly increased seroconversion rates and antibody titers. Two fIPV doses together use two-fifth of the vaccine compared to one full-dose IPV. In response to the current IPV shortage, a schedule of two fIPV doses at ages 6 and 14weekshas been endorsed by technical oversight committees and has been introduced in some affected countries.
引用
- Anand A, Molodecky NA, Pallansch MA, et al. Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization schedule. Vaccine. 2017. PMID: 28434691. doi:10.1016/j.vaccine.2017.03.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。